AstraZeneca and Johnson & Johnson to resume COVID-19 vaccine trials as U.S. daily cases top 71,000

Upworthy

24 Oct 2020 0 shares 1 views

Upworthy

Published 24 Oct 2020

On Friday, both AstraZeneca and Johnson & Johnson announced their coronavirus vaccine trials are set to resume in the U.S. after hitting...

Johnson & Johnson Covid-19 Vaccine On Hold

Watch VideoThe race for an approved COVID-19 vaccine is dealing with a setback. Johnson & Johnson has paused their late stage..

Newsy 13 Oct 2020

Pfizer Inc. (NYSE:PFE) is hoping to manufacture and distribute 100mln doses of the COVID-19 vaccine it is developing with BioNTech..

Proactive Investors 19 Oct 2020